The intratumoral microbiome: a review of the tumor microenvironment’s fourth axis shaping anti-tumor immunity, cancer prognosis, and therapeutic response - Top-Institutions - MDSpire

The intratumoral microbiome: a review of the tumor microenvironment’s fourth axis shaping anti-tumor immunity, cancer prognosis, and therapeutic response

  • By

  • Joseph G. L. Hunter

  • Alexandra Roach

  • Lizbeth Nieves

  • Ariana Islas

  • Andrew Islas

  • Michelle DiPalma

  • June 4, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

  • #2

    Veterans Affairs Ann Arbor Healthcare System
    Veterans Affairs Ann Arbor Healthcare System

    Ann Arbor, Michigan

    Key Differentiators

    • Oncology

  • #3

    U.S. Veterans Health Administration
    U.S. Veterans Health Administration

    Washington, D.C.

    Key Differentiators

    • Oncology

  • #4

    New York Eye and Ear Infirmary of Mount Sinai
    New York Eye and Ear Infirmary of Mount Sinai

    New York, New York

    Key Differentiators

    • Ophthalmology
    • Oncology

  • #5

    Huashan Hospital, Fudan University
    Huashan Hospital, Fudan University

    Shanghai, China

    Key Differentiators

    • Oncology

Original Source(s)

The intratumoral microbiome: a review of the tumor microenvironment’s fourth axis shaping anti-tumor immunity, cancer prognosis, and therapeutic response

  • by Joseph G. L. Hunter, Alexandra Roach, Lizbeth Nieves, Ariana Islas, Andrew Islas, Michelle DiPalma

  • June 4, 2026

Related Content

Interaction of CD99 and its ligands regulates immunoregulatory pathways in NK cells

Emerging insights into the role of BDH1 in the pathogenesis of human cancer

Grail’s multi-cancer early detection trial was negative. But as an oncologist, I see more to this story